Navigation Links
Januvia Lawsuit News: Rottenstein Law Group LLP Comments on Doctor’s Doubts About Januvia
Date:5/31/2013

(PRWEB) May 31, 2013

Merck’s diabetes drug Januvia can potentially cause pancreatic cancer, according to the research of Dr. Peter C. Butler reported in the New York Times.* The Rottenstein Law Group, which accepts clients in Januvia lawsuits, maintains a site at http://www.januvialawsuits.us that features information about the drug’s alleged side effects and eligibility for filing a lawsuit.

Butler, chairman of endocrinology at the University of California, Los Angeles, has been researching Januvia since 2008, when Merck asked him to determine if the drug could stave off disease in rats, according to the Times. What Butler found is changes in the pancreases of rats that could lead to cancer. His findings are having an impact on not only Januvia, but also sales of other type 2 diabetes drugs such as Byetta and Victoza, that are also linked to pancreatic cancer. His findings have led the U.S. Food and Drug Administration and its European counterpart to consider further investigation.

“If Dr. Butler’s findings are true, then Merck should be held accountable for the alleged Januvia side effects,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “Accountability in this case means that those who believed their medication has harmed them should have the opportunity to be compensated for their alleged harms.”

At its Januvia Lawsuits Center, the Rottenstein Law Group LLP features information on all the serious side effects of Januvia, news on the drug and information about how to file a Januvia lawsuit.

*nytimes.com/2013/05/31/business/a-doctor-raises-questions-about-a-diabetes-drug.html?pagewanted=all

For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP’s Injury Lawyer Newswire at injurylawyernewswire.com. Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

                            ###

Read the full story at http://www.prweb.com/releases/januvia-lawsuit/pancreatic-cancer/prweb10787304.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Announces Addition of Januvia Cancer Resource Center
2. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
3. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
4. Januvia Lawsuits Consultations Now Offered by the Berman Law Group, Januvia Lawyers and Compensation Experts
5. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
6. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
7. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
8. New Lawsuit Alleges Teen Molestation by Ex-Deputy
9. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
10. New Lawsuit on Propecia: Severe Adverse Events
11. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 27, 2017 , ... Advantexe Learning Solutions , a ... a new research study, The Business Readiness Report. The report explores the correlation ... the actual success of achieving individual and company goals. , There are ...
(Date:3/27/2017)... ... 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award ... a long time,” she said. , She thinks the coming week is going to be ... I would have to help my students.” , The award will allow the 4th grade ...
(Date:3/27/2017)... Mt. Angel, Oregon (PRWEB) , ... March 27, ... ... supplements company, is pleased to announce the launch of a months-long rebranding effort. ... exciting new formulations. , “Through focus group discussions and market research, we learned ...
(Date:3/27/2017)... ... 27, 2017 , ... The homeowner improvement and repair market is expected to ... unlicensed contractors for renovations is also on the rise. Per a 2017 report, 13% ... those, 42% failed to use a licensed contractor.(2) The risks associated with improper renovations—especially ...
(Date:3/25/2017)... ... 25, 2017 , ... Norland at Swissray is pleased to announce the release of ... The ELITE DXA has an active scan window, which is more than double that of ... the scan area could not undergo an accurate total body bone density or body composition ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") ... pleased to announce it has received conditional approval to ... Venture Exchange.  Receiving the conditional listing ... achievements for Invictus-MD. Some of which include: ... Inc. ("AB Labs"), a Licensed Producer under the Access ...
(Date:3/27/2017)... 2017  BERG, a biopharmaceutical company uncovering ... approach, today announced that the company,s Interrogative ... new data using a cold-induced model to ... Joslin Diabetes Center led the investigation with ... analysis of samples.  The findings were published ...
(Date:3/27/2017)... , March 27, 2017  iCAD (Nasdaq: ICAD), ... solutions and radiation therapy for the early identification ... Tomo Detection received Premarket Approval (PMA) from the ... Detection is a first-of-its-kind, concurrent-read computer aided detection ... the latest innovation available on the PowerLook® Breast ...
Breaking Medicine Technology: